The impact of new life sciences innovations has been blunted by a disconnect between how these innovations are designed and how patients ultimately experience them. Cognizant’s human-centered approach bridges this gap, aligning new technology’s conceptual value with its practical application, to speed new treatments to market and improve patient outcomes.
From targeting the right clinical trial candidates to personalizing each patient’s treatment, the discovery and delivery of cell and gene therapies requires a transformation of the typical product lifecycle. In this webinar, industry experts provide recommendations for evolving your organization to accelerate the delivery of these life-changing treatments.
Senior Vice President and R&D Practice Leader, Life Sciences, Cognizant
Global Director of Technical Operations for Zenith Technologies, a Cognizant Company
Head of IT and GxP Digital, Tmunity Therapeutics
Head of Commercial, Manufacturing Innovation Centre, Cell and Gene Therapy Catapult
Cell and gene therapies will require a fundamental shift in life sciences organizations’ approach to manufacturing
Life sciences & the cloud: room – and reason – for growth
It takes a village to humanize the clinical trial experience